Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m

Journal of Physiology

Volumn 590, Issue 5, 2012, Pages 1213-1225

  Fan, Jui Lin ^a,d,e   Burgess, Keith R ^e   Thomas, Kate N ^a   Lucas, Samuel J E ^a,b   Cotter, James D ^b   Kayser, Bengt ^c   Peebles, Karen C ^a   Ainslie, Philip N ^f  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ACUTE DRUG ADMINISTRATION; ADULT; ALTITUDE ACCLIMATIZATION; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN PERFUSION; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERCAPNIA; HYPOCAPNIA; HYPOXIA; LUNG MINUTE VOLUME; MALE; MIDDLE CEREBRAL ARTERY; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATION CONTROL; RESPIRATORY DRIVE; SINGLE DRUG DOSE; WAKEFULNESS;

ACETAZOLAMIDE; ADULT; ALTITUDE; BLOOD GAS ANALYSIS; BRAIN; CARBON DIOXIDE; CARBONIC ANHYDRASE INHIBITORS; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; PULMONARY VENTILATION; REGIONAL BLOOD FLOW; RESPIRATION; YOUNG ADULT;

EID: 84857681847     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.219923     Document Type: Article

References (63)

1. Aaslid R, Markwalder TM & Nornes H (1982). Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57, 769-774.
2. 2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement and interpretation. Am J Physiol Regul Integr Comp Physiol 296, R1473-R1495.
3. Brusil PJ, Waggener TB, Kronauer RE & Gulesian P Jr (1980). Methods for identifying respiratory oscillations disclose altitude effects. J Appl Physiol 48, 545-556.
4. Brzezinski J, Kjallquist A & Siesjo BK (1967). Mean carbon dioxide tension in the brain after carbonic anhydrase inhibition. J Physiol 188, 13-23.
5. Burki NK, Khan SA & Hameed MA (1992). The effects of acetazolamide on the ventilatory response to high altitude hypoxia. Chest 101, 736-741.
6. Cherniack NS & Longobardo GS (1973). Cheyne-Stokes breathing. An instability in physiologic control. N Engl J Med 288, 952-957.
7. 2. J Physiol 441, 433-451.
8. Cunningham DJ, Hey EN, Patrick JM & Lloyd BB (1963). The effect of noradrenaline infusion on the relation between pulmonary ventilation and the alveolar and in man. Ann N Y Acad Sci 109, 756-771.
9. Day TA & Wilson RJ (2009). A negative interaction between brainstem and peripheral respiratory chemoreceptors modulates peripheral chemoreflex magnitude. J Physiol 587, 883-896.
10. Dempsey JA (2005). Crossing the apnoeic threshold: causes and consequences. Exp Physiol 90, 13-24.
11. Duffin J, Mohan RM, Vasiliou P, Stephenson R & Mahamed S (2000). A model of the chemoreflex control of breathing in humans: model parameters measurement. Respir Physiol 120, 13-26.
12. Ehrenreich DL, Burns RA, Alman RW & Fazekas JF (1961). Influence of acetazolamide on cerebral blood flow. Arch Neurol 5, 227-232.
13. 2. J Physiol 588, 539-549.
14. 2 and breathing stability: the influence of gradients. Am J Physiol Regul Integr Comp Physiol 298, R1648-R1658.
15. Fontana M, Emdin M, Giannoni A, Iudice G, Baruah R & Passino C (2011). Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. Am J Cardiol 107, 1675-1680.
16. Gardner WN (1980). The pattern of breathing following step changes of alveolar partial pressures of carbon dioxide and oxygen in man. J Physiol 300, 55-73.
17. Gotoh F, Meyer JS & Takagi Y (1969). Cerebral venous and arterial blood gases during Cheyne-Stokes respiration. Am J Med 47, 534-545.
18. Grandin CB, Bol A, Smith AM, Michel C & Cosnard G (2005). Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatabilily and comparison with PET in humans. Neuroimage 26, 525-535.
19. Hackett PH, Roach RC, Harrison GL, Schoene RB & Mills WJ Jr (1987). Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis 135, 896-898.
20. Hauge A, Nicolaysen G & Thoresen M (1983). Acute effects of acetazolamide on cerebral blood flow in man. Acta Physiol Scand 117, 233-239.
21. Hayes MW, Maini BK & Torrances RW (1976). Reduction of the responses of carotid chemoreceptors by acetazolamide. In Morphology and Mechanisms of Chemoreceptors, ed. Paintal AS, pp. 36-45. Valabhbhai Patel Chest Institute, Delhi, India
22. Iturriaga R, Lahiri S & Mokashi A (1991). Carbonic anhydrase and chemoreception in the cat carotid body. Am J Physiol Cell Physiol 261, C565-C573.
23. Javaheri S (2006). Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 173, 234-237.
24. Jensen JB, Wright AD, Lassen NA, Harvey TC, Winterborn MH, Raichle ME & Bradwell AR (1990). Cerebral blood flow in acute mountain sickness. J Appl Physiol 69, 430-433.
25. Khoo MC, Kronauer RE, Strohl KP & Slutsky AS (1982). Factors inducing periodic breathing in humans: a general model. J Appl Physiol 53, 644-659.
26. Lahiri S & Data PG (1992). Chemosensitivity and regulation of ventilation during sleep at high altitudes. Int J Sports Med 13, S31-S33.
27. Lahiri S, Delaney GA & Fisheman AP (1976). Peripheral and central effects of acetazolamide on control of ventilation. Physiologist 19, 261.
28. Lahiri S, Maret K & Sherpa MG (1983). Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol 52, 281-301.
29. 2. Brain Res 234, 137-147.
30. LaManna JC & McCracken KA (1990). Carbonic anhydrase inhibition and cerebral cortical oxygenation in the rat. Adv Exp Med Biol 277, 335-343.
31. Lassen NA, Friberg L, Kastrup J, Rizzi D & Jensen JJ (1987). Effects of acetazolamide on cerebral blood flow and brain tissue oxygenation. Postgrad Med J 63, 185-187.
32. Lucas SJ, Burgess KR, Thomas KN, Donnelly J, Peebles KC, Lucas RA, Fan JL, Cotter JD, Basnyat R & Ainslie PN (2011). Alterations in cerebral blood flow and cerebrovascular reactivity during 14 days at 5050 m. J Physiol 589, 741-753.
33. Mathew L, Gopinath PM, Purkayastha SS, Gupta Sen J & Nayar HS (1983). Chemoreceptor sensitivity in adaptation to high altitude. Aviat Space Environ Med 54, 121-126.
34. Mirrakhlmov M, Brimkulov N, Cieslicki J, Tobiasz M, Kudaiberdiev Z, Moldotashev I, Shmidt G & Zielinski J (1993). Effects of acetazolamide on overnight oxygenation and acute mountain sickness in patients with asthma. Eur Respir J 6, 536-540.
35. Mohan RM, Amara CE, Cunningham DA & Duffin J (1999). Measuring central-chemoreflex sensitivity in man: rebreathing and steady-state methods compared. Respir Physiol 115, 23-33.
36. 2 saturation in relation to sleep stages at high altitude. Aviat Space Environ Med 61, 229-235.
37. Posner JB & Plum F (1960). The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest 39, 1246-1258.
38. Schoene RB, Bates PW, Larson EB & Pierson DJ (1983). Effect of acetazolamide on normoxic and hypoxic exercise in humans at sea level. J Appl Physiol 55, 1772-1776.
39. Schreiber SJ, Gottschalk S, Weih M, Villringer A & Valdueza JM (2000). Assessment of blood flow velocity and diameter of the middle cerebral artery during the acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging. AJNR Am J Neuroradiol 21, 1207-1211.
40. Subudhi AW, Dimmen AC, Julian CG, Wilson MJ, Panerai RB & Roach RC (2011). Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia. J Appl Physiol 110, 1219-1225.
41. Sutton JR, Gray GW, Houston CS & Powles AC (1980). Effects of duration at altitude and acetazolamide on ventilation and oxygenation during sleep. Sleep 3, 455-464.
42. Sutton JR, Houston CS, Mansell AL, McFadden MD, Hackett PM, Rigg JR & Powles AC (1979). Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med 301, 1329-1331.
43. Swenson ER (1998). Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J 12, 1242-1247.
44. Swenson ER & Hughes JM (1993). Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol 74, 230-237.
45. Teppema L, Berkenbosch A, DeGoede J & Olievier C (1995). Carbonic anhydrase and control of breathing: different effects of benzolamide and methazolamide in the anaesthetized cat. J Physiol 488, 767-777.
46. Teppema LJ, Balanos GM, Steinback CD, Brown AD, Foster GE, Duff HJ, Leigh R & Poulin MJ (2007). Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am J Respir Crit Care Med 175, 277-281.
47. Teppema LJ, Bijl H, Romberg RR & Dahan A (2006). Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. J Physiol 572, 849-856.
48. 2 sensitivity? Am J Respir Crit Care Med 160, 1592-1597.
49. Teppema LJ & Dahan A (2004). Low-dose acetazolamide reduces the hypoxic ventilatory response in the anesthetized cat. Respir Physiol Neurobiol 140, 43-51.
50. 2 stimulus interaction within the peripheral chemoreceptors in the anaesthetised cat. J Physiol 537, 221-229.
51. Teppema LJ, Rochette F & Demedts M (1992). Ventilatory effects of acetazolamide in cats during hypoxemia. J Appl Physiol 72, 1717-1723.
52. +] and the ventilatory response to hypoxia in humans: influence of acetazolamide-induced metabolic acidosis. Am J Physiol Lung Cell Mol Physiol 298, L89-L95.
53. Thomas KN, Burgess KR, Basnyat R, Lucas SJ, Cotter JD, Fan JL, Peebles KC, Lucas RA & Ainslie PN (2010). Initial orthostatic hypotension at high altitude. High Alt Med Biol 11, 163-167.
54. Vorstrup S, Henriksen L & Paulson OB (1984). Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 74, 1634-1639.
55. Vorstrup S, Jensen KE, Thomsen C, Henriksen O, Lassen NA & Paulson OB (1989). Neuronal pH regulation: constant normal intracellular pH is maintained in brain during low extracellular pH induced by acetazolamide-31P NMR study. J Cereb Blood Flow Metab 9, 417-421.
56. Vuyk J, Bos Van Den J, Terhell K, Bos De R, Vletter A, Valk P, Beuzekom Van M, Kleef Van J & Dahan A (2006). Acetazolamide improves cerebral oxygenation during exercise at high altitude. High Alt Med Biol 7, 290-301.
57. Waggener TB, Brusil PJ, Kronauer RE, Gabel RA & Inbar GF (1984). Strength and cycle time of high-altitude ventilatory patterns in unacclimatized humans. J Appl Physiol 56, 576-581.
58. Weil JV, Kryger MH & Scoggin CH (1978). Sleep and breathing at high altitude. In Sleep Apnea Syndromes, ed. Guilleminault C & Dement WC, pp. 119-136. Liss, New York
59. Wilson MH, Edsell ME, Davagnanam I, Hirani SP, Martin DS, Levett DZ, Thornton JS, Golay X, Strycharczuk L, Newman SP, Montgomery HE, Grocott MP & Imray CH (2011). Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia - an ultrasound and MRI study. J Cereb Blood Flow Metab 31, 2019-2029.
60. Xie A, Skatrud JB, Barczi SR, Reichmuth K, Morgan BJ, Mont S & Dempsey JA (2009). Influence of cerebral blood flow on breathing stability. J Appl Physiol 106, 850-856.
61. 2 in sleeping humans. J Physiol 535, 269-278.
62. Xie A, Skatrud JB, Khayat R, Dempsey JA, Morgan B & Russell D (2005). Cerebrovascular response to carbon dioxide in patients with congestive heart failure. Am J Respir Crit Care Med 172, 371-378.
63. 2 on the susceptibility to posthyperventilation apnea during sleep. J Appl Physiol 100, 171-177.